Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC477914560;14561;14562 chr2:178738118;178738117;178738116chr2:179602845;179602844;179602843
N2AB446213609;13610;13611 chr2:178738118;178738117;178738116chr2:179602845;179602844;179602843
N2A353510828;10829;10830 chr2:178738118;178738117;178738116chr2:179602845;179602844;179602843
N2B441613471;13472;13473 chr2:178738118;178738117;178738116chr2:179602845;179602844;179602843
Novex-1454113846;13847;13848 chr2:178738118;178738117;178738116chr2:179602845;179602844;179602843
Novex-2460814047;14048;14049 chr2:178738118;178738117;178738116chr2:179602845;179602844;179602843
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Ig-30
  • Domain position: 80
  • Structural Position: 164
  • Q(SASA): 0.2533
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 1.0 D 0.835 0.771 0.551593237191 gnomAD-4.0.0 1.59144E-06 None None None None I None 0 0 None 0 0 None 0 0 0 0 3.02425E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.7322 likely_pathogenic 0.8592 pathogenic -0.385 Destabilizing 1.0 D 0.749 deleterious D 0.69022132 None None I
G/C 0.9171 likely_pathogenic 0.959 pathogenic -0.978 Destabilizing 1.0 D 0.789 deleterious D 0.838748861 None None I
G/D 0.9018 likely_pathogenic 0.953 pathogenic -0.517 Destabilizing 1.0 D 0.835 deleterious D 0.687846681 None None I
G/E 0.9396 likely_pathogenic 0.9739 pathogenic -0.679 Destabilizing 1.0 D 0.82 deleterious None None None None I
G/F 0.9844 likely_pathogenic 0.9917 pathogenic -1.094 Destabilizing 1.0 D 0.817 deleterious None None None None I
G/H 0.9686 likely_pathogenic 0.9854 pathogenic -0.558 Destabilizing 1.0 D 0.789 deleterious None None None None I
G/I 0.976 likely_pathogenic 0.9903 pathogenic -0.541 Destabilizing 1.0 D 0.822 deleterious None None None None I
G/K 0.9648 likely_pathogenic 0.9835 pathogenic -0.804 Destabilizing 1.0 D 0.819 deleterious None None None None I
G/L 0.9741 likely_pathogenic 0.988 pathogenic -0.541 Destabilizing 1.0 D 0.807 deleterious None None None None I
G/M 0.9869 likely_pathogenic 0.9944 pathogenic -0.557 Destabilizing 1.0 D 0.785 deleterious None None None None I
G/N 0.9311 likely_pathogenic 0.9656 pathogenic -0.503 Destabilizing 1.0 D 0.795 deleterious None None None None I
G/P 0.9966 likely_pathogenic 0.998 pathogenic -0.457 Destabilizing 1.0 D 0.839 deleterious None None None None I
G/Q 0.9404 likely_pathogenic 0.972 pathogenic -0.79 Destabilizing 1.0 D 0.842 deleterious None None None None I
G/R 0.9051 likely_pathogenic 0.9495 pathogenic -0.353 Destabilizing 1.0 D 0.845 deleterious D 0.759208855 None None I
G/S 0.5786 likely_pathogenic 0.7248 pathogenic -0.67 Destabilizing 1.0 D 0.803 deleterious D 0.706517345 None None I
G/T 0.9119 likely_pathogenic 0.9555 pathogenic -0.761 Destabilizing 1.0 D 0.815 deleterious None None None None I
G/V 0.9561 likely_pathogenic 0.9813 pathogenic -0.457 Destabilizing 1.0 D 0.809 deleterious D 0.805342699 None None I
G/W 0.9784 likely_pathogenic 0.9882 pathogenic -1.214 Destabilizing 1.0 D 0.799 deleterious None None None None I
G/Y 0.9754 likely_pathogenic 0.9878 pathogenic -0.881 Destabilizing 1.0 D 0.815 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.